Number of pages: 100 | Report Format: PDF | Published date: January 19, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
Report Attribute |
Details |
Market Size Value in 2021 |
US$ 15.20 billion |
Revenue Forecast in 2030 |
US$ 32.23 billion |
CAGR |
7.80% |
Base Year for Estimation |
2021 |
Forecast period |
2022-2030 |
Historical Year |
2020 |
Segments Covered |
Product Type, Application, End-user, and Region |
Regional Scope |
North America, Europe, Asia Pacific, and the Rest of the World (RoW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global mass spectrometry market was valued at US$ 15.20 billion in 2021 and is expected to register a revenue CAGR of 7.80% to reach US$ 32.23 billion by 2030.
Mass Spectrometry Market Fundamentals
Mass spectrometry is a technique for determining the mass-to-charge ratio (m/z) of one or more molecules in a sample. These data are frequently used to compute the precise molecular weight of the sample components. Mass spectrometers are often used to identify unknown chemicals by determining molecular weight, quantifying known compounds, and analyzing the structure and chemical characteristics of molecules. Mass spectroscopy is primarily employed in R&D projects in a variety of industrial sectors, such as food, life sciences, and pharmaceuticals.
Key factors driving revenue growth in the mass spectrometry market include advancements in mass spectrometer technology and growing global concerns about food safety. The major industry players are focusing on enhancing their current offerings and launching brand-new, state-of-the-art mass spectrometer gadgets. Furthermore, the comprehensive product offerings from major players have made it easier for consumers to select a specific mass spectrometer based on their accuracy requirements.
[4525432]
Mass Spectrometry Market Dynamics
The COVID-19 outbreak had a positive impact on the global mass spectrometry market. The pandemic resulted in high demand for multiple spectrometers from the biotechnology and pharmaceutical industries. Researchers at the Institute of Genomics and Integrative Biology (IGIB), Delhi, and the National Center for Disease Control (NCDC) used a mass spectrometer to identify a novel coronavirus (COVID-19) with 95% sensitivity and 100% precision in comparison to RT-PCR. MAP Sciences, a UK-based diagnostics firm, announced the development of a rapid test for the COVID-19 virus in April 2020. This technology detects different proteins in COVID-19 using multiple spectrometry and is designed to provide test results in 30 minutes. These developments are projected to fuel revenue growth in the market.
Mass Spectrometry Market Ecosystem
The global mass spectrometry market is analyzed from four perspectives: product type, application, end-user, and region.
Mass Spectrometry Market by Product Type
Based on the product type, the global mass spectrometry market is segmented into hybrid, single, and others.
The hybrid segment accounts for the largest revenue share of the market, and it is expected to register the fastest revenue CAGR during the forecast period. Demand for a hybrid mass spectrometer is growing, especially in developed countries, due to its advantages, such as rapid, high-resolution results with improved precision. This factor is expected to fuel revenue growth in the segment during the forecast period.
Mass Spectrometry Market by Application
Based on the application, the global mass spectrometry market is segmented into pharmaceutical analysis, forensic analysis, proteomics, and metabolomics.
The pharmaceutical analysis segment accounts for the largest revenue share of the market. This is attributed to rise in the usage of mass spectrometry in the precise identification of a component in a mixture, which is critical as incorrect identification of individual elements can lead to dangerous situations. Mass spectrometers are now widely used in the pharmaceutical industry for a variety of applications ranging from the early stages of drug discovery to the final stages of development and clinical trials.
Mass Spectrometry Market by End User
[2452424]
Based on the end-user, the global mass spectrometry market is segmented into pharmaceutical & biotechnology, food & beverage testing, and environmental testing.
The pharmaceutical & biotechnology segment dominates the market with the largest revenue share and is expected to register the highest revenue CAGR during the forecast period. Pharmaceutical analysis is a group of processes that determine, identify, purify, and quantify a substance, determine the structure of chemical compounds, or separate the components of a solution or mixture.
Mass Spectrometry Market by Region
Based on the region, the global mass spectrometry market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).
North America dominates the global mass spectrometry market due to a strong base of healthcare facilities, rising investment from key players in the development of advanced devices, increasing number of drug development processes, favorable government funding programs for research studies that use mass spectrometry, stringent regulations in the pharmaceutical industry, and increasing number of R&D activities in this region.
The market in Asia Pacific is expected to grow swiftly, due to increased government initiatives to support the regional biotechnology and pharmaceuticals industry, expansion of the medical tourism industry, growth in the R&D activities in the region, rise in the utilization of mass spectrometry in the pharmaceutical industry and in food testing processes, and increase in demand for quality healthcare in the region. Growing regulations in terms of environment and food safety are also facilitating the revenue growth in demand for mass spectrometry technologies in Asia Pacific.
Mass Spectrometry Market Competitive Landscape
The prominent players in the global mass spectrometry market include:
Mass Spectrometry Market Strategic Developments
In March 2022, Shinmadzu Company released a multi-omics analysis package. It is a metabolic engineering software that generates metabolic maps.
Technological advancements in the spectrometry systems, and increased R&D spending by pharmaceutical companies and government research organizations are the key factors driving the revenue growth of the spectrometry market.
Agilent Technologies, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Waters Corporation, and Bruker Corporation are among the key players operating in the global mass spectrometry market.
The pharmaceutical and biotechnology segment dominates the global mass spectrometry market with the largest revenue share.
North America dominates the mass spectrometry market and is expected to register the highest revenue growth during the forecast period.
*Insights on financial permanence are subject to the availability of information in the public domain